a
e

Talu ai nei, na faasilasila ai e le JYMed Technology Co., Ltd. le Leuprorelin Acetate, na gaosia e lona lala o Hubei JX Bio-Pharmaceutical Co., Ltd., ua faamanuiaina ma le manuia le siakiina o le resitalaina o fualaau faasaina.

Uluai Va'aiga Va'aiga Va'aiga Maketi

Leuprorelin Acetate o se vailaʻau tui e faʻaaogaina e togafitia ai faʻamaʻi faʻalagolago i le hormone, faʻatasi ai ma le fua mole C59H84N16O12•xC2H4O2. O se gonadotropin-releasing hormone agonist (GnRHa) e galue e ala i le faʻalavelaveina o le pituitary-gonadal system. Muamua na fausia e AbbVie ma Takeda Pharmaceutical, o lenei vailaʻau o loʻo maketiina i lalo o igoa eseese i atunuu eseese. I totonu o le Iunaite Setete, o loʻo faʻatau atu i lalo o le igoa LUPRON DEPOT, aʻo Saina, o loʻo faʻatau atu o Yina Tong.

Fa'amanino Fa'agasologa ma Matafaioi Fa'amanino

Mai le 2019 i le 2022, na maeʻa suʻesuʻega ma atinaʻe vailaʻau, sosoo ai ma le resitalaina o le API ia Mati 2024, ina ua maua le faʻaaliga o le taliaina. O le siakiina o le resitalaina o fualaau faasaina na pasia ia Aokuso 2024. O le JYMed Technology Co., Ltd. sa nafa ma le atinaʻeina o le faʻagasologa, atinaʻeina o metotia suʻesuʻe, suʻesuʻega le mama, faʻamaoniga o fausaga, ma le faʻamaoniaina o metotia. O le Hubei JX Bio-Pharmaceutical Co., Ltd. sa nafa ma le faʻagasologa o le faʻamaoniaina o le gaosiga, faʻamaoniga o metotia suʻesuʻe, ma suʻesuʻega mautu mo le API.

Faʻateleina Maketi ma Faʻateleina Manaʻoga

O le siʻitia o aʻafiaga o le kanesa prostate ma uterine fibroids o loʻo faʻateleina ai le manaʻoga mo le Leuprorelin Acetate. O le maketi a Amerika i Matu o loʻo pulea nei le maketi o le Leuprorelin Acetate, faʻatasi ai ma le faʻatupulaia o tupe faʻaalu mo le soifua maloloina ma le maualuga o le taliaina o tekinolosi fou e avea ma faʻauluuluga o le tuputupu aʻe. I le taimi lava e tasi, o le maketi Asia, aemaise lava Saina, o loʻo faʻaalia foi le manaʻoga malosi mo Leuprorelin Acetate. Ona o lona aoga, o loʻo faʻatupulaʻia le manaʻoga o le lalolagi mo lenei vailaʻau, faʻatasi ai ma le maketi o loʻo faʻamoemoe e oʻo atu i le $ 3,946.1 miliona i le 2031, e atagia mai ai le aofaʻi o le tuputupu aʻe faaletausaga (CAGR) o le 4.86% mai le 2021 i le 2031.

E uiga i le JYMed

i

Shenzhen JYMed Technology Co., Ltd. (lea ua taʻua mulimuli ane o le JYMed) na faavaeina i le 2009, faʻapitoa i le suʻesuʻega, atinaʻe, gaosiga, ma le faʻatau atu o peptides ma peptide-related products. Faatasi ai ma le tasi nofoaga autu suʻesuʻe ma tolu faʻavae gaosiga tetele, JYMed o se tasi o le tele o gaosiga o chemically synthesized peptide APIs i Saina. O le vaega autu R&D a le kamupani o loʻo faʻamaualuga i luga o le 20 tausaga o le poto masani i le alamanuia peptide ma ua faʻamanuiaina faʻalua asiasiga a le FDA. O le JYMed's comprehensive and efficient peptide industrialization system e ofoina atu i tagata faatau le tele o auaunaga, e aofia ai le atinaʻeina ma le gaosiga o peptides togafitiga, peptides veterinary, peptides antimicrobial, ma peptides cosmetic, faʻapea foʻi ma le resitalaina ma le lagolago faʻatonutonu.

Galuega Autu Pisinisi

1. Faʻamaumauga faʻapitonuʻu ma faavaomalo o peptide APIs
2. Veterinary ma cosmetic peptides
3.Custom peptides ma CRO, CMO, auaunaga OEM
4.PDC fualaau (peptide-radionuclide, peptide-laiti mole, peptide-protein, peptide-RNA)

I le faaopoopo atu i le Leuprorelin Acetate, ua tuʻuina atu e le JYMed faila resitalaina ma le FDA ma le CDE mo le tele o isi oloa API, e aofia ai vailaʻau faʻapitoa GLP-1RA e pei o Semaglutide, Liraglutide ma Tirzepatide. O tagata fa'atau i le lumana'i o lo'o fa'aogaina oloa a le JYMed o le a mafai ona fa'asino sa'o le numera o le resitalaina CDE po'o le numera faila DMF pe a tu'uina atu tusi talosaga ile FDA po'o le CDE. O lenei mea o le a faʻaitiitia ai le taimi e manaʻomia mo le sauniaina o pepa talosaga, faʻapea foʻi ma le taimi o le iloiloga ma le tau o le iloiloga o oloa.

o

Faafesootai matou

f
u

Shenzhen JYMed Technology Co., Ltd.
tuatusi:8th & 9th Floors, Fale 1, Shenzhen Biomedical Innovation Industrial Park, Numera 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen
Telefoni:+86 755-26612112
Upega tafa'ilagi:http://www.jymedtech.com/


Taimi meli: Aukuso-29-2024
;